Camber Launches Spironolactone Tablets
Camber Pharmaceuticals continues to expand its portfolio of treatment options with the launch of Spironolactone Tablets [spir-ON-oh-LAK-tone].
Spironolactone Tablets are indicated for treatment of Heart Failure, Hypertension, Edema Associated with Hepatic Cirrhosis or Nephrotic Syndrome, and Primary Hyperaldosteronism.
For complete indications, click here.
Spironolactone Tablets are available in:
| Strength | Size |
| 25 mg | 100, 500, and 1,000 ct |
| 50 mg | 100 and 500 ct |
| 100 mg | 100 and 500 ct |






